List of Figures
- Figure 1: Global Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
- Figure 2: Global Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
- Figure 3: Global Number of regenerative medicine Companies, By Region, 2018
- Figure 4: Biotechnology Research and Development Services Cost Index, In 2018
- Figure 5: Clinical trials of regenerative medicine, By Type, In number, In 2018
- Figure 6: Clinical trials of regenerative medicine, By Application, In number, In 2018
- Figure 7: Financing for Regenerative Medicines, By Type, In USD million, In 2018
- Figure 8: Financing for Regenerative Medicines, By Organizations, In USD million, In 2018
- Figure 9: Causes of premature (under age 70) NCD mortality, 2017 (%)
- Figure 10: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
- Figure 11: Number of New Cases of Cancer, In 2018, By Region, (% of Total)
- Figure 12: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total)
- Figure 13: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
- Figure 14: Projected increase in cases of diabetes in 2045, By region (In Percentage)
- Figure 15: Prevalence of musculoskeletal condition worldwide, 2013-2020E, In billion
- Figure 16: Prevalence of cardiovascular diseases worldwide, 2013-2018, In million
- Figure 17: Prevalence of chronic respiratory diseases worldwide, 2013-2020E, In million
- Figure 18: Prevalence of skin diseases worldwide, 2013-2020E, In million
- Figure 19: GDP Per Capita PPP, By Region, In 2018 (in Thousand USD)
- Figure 20: Projected global population aged 60 years & above (In Millions)
- Figure 21: Global Regenerative Medicine Market Size, By Type, 2018 (%)
- Figure 22: Global Regenerative Medicine Market Size, By Type, 2024F (%)
- Figure 23: Global Regenerative Medicine Market Size, By Type, 2018 (In %)
- Figure 24: Global Regenerative Medicine Market Size, By Type, 2024 (In %)
- Figure 25: Global Cell Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 26: Global Cell Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 27: Global Gene Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 28: Global Gene Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 29: Global Tissue Engineered Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 30: Global Tissue Engineered Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 31: Market Opportunity Chart of global regenerative medicine Market - By Type, By Value (Year - 2024)
- Figure 32: Global Regenerative Medicine Market Size, By Application, 2018 (%)
- Figure 33: Global Regenerative Medicine Market Size, By Application, 2024F (%)
- Figure 34: Global Regenerative Medicine Market Size, By Application, 2018 (In %)
- Figure 35: Global Regenerative Medicine Market Size, By Application, 2024 (In %)
- Figure 36: Global Orthopaedic & Dental Market, By Value, 2014-2018 (USD Million)
- Figure 37: Global Orthopaedic & Dental Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 38: Global Cardiology Market, By Value, 2014-2018 (USD Million)
- Figure 39: Global Cardiology Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 40: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 41: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 42: Global Metabolism & Inflammatory Market, By Value, 2014-2018 (USD Million)
- Figure 43: Global Metabolism & Inflammatory Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 44: Global Immunology & Oncology Market, By Value, 2014-2018 (USD Million)
- Figure 45: Global Immunology & Oncology Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 46: Global Others Market, By Value, 2014-2018 (USD Million)
- Figure 47: Global Others Market, By Value, Forecast, 2019-2024 (USD Million)
- Figure 48: Market Opportunity Chart of global regenerative medicine Market - By Application, By Value (Year - 2024)
- Figure 49: Global Healthcare Landscape, By Select Region
- Figure 50: Global Regenerative Medicine Market Size, By Region, 2018 (%)
- Figure 51: Global Regenerative Medicine Market Size, By Region, 2024 (%)
- Figure 52: North America Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
- Figure 53: North America Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
- Figure 54: North America Diseases Outlook
- Figure 55: United States health care expenditure per capita, (In USD)
- Figure 56: Canada health care expenditure per capita (In USD)
- Figure 57: North America population aged 65 and above, 2013-2018 (% of total)
- Figure 58: Prevalence of musculoskeletal condition in North America, In million, 2013-2020E
- Figure 59: Prevalence of skin diseases in North America, In million. 2013-202E
- Figure 60: Prevalence of cardiovascular disease in North America, In million
- Figure 61: North America GDP, 2012-2017 (USD Trillion)
- Figure 62: North America GDP per capita, current prices, 2013-2023F (In USD)
- Figure 63: North America Regenerative Medicine Market: Prominent Companies (2018)
- Figure 64: North America Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 65: North America Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 66: North America Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 67: North America Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 68: North America Regenerative Medicine Market Size, By Country, 2018 (%)
- Figure 69: North America Regenerative Medicine Market Size, By Country, 2024F (%)
- Figure 70: Market Opportunity Chart of North America Regenerative Medicine Market - By Type, By Value (Year - 2024)
- Figure 71: USA Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 72: USA Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 73: Clinical trials supported by CIRM, By Disease, In 2018
- Figure 74: Percentage of adults aged 18-64 with insurance coverage in United States, By Poverty status, In 2018
- Figure 75: Percentage of individuals with insurance coverage in United States, By Age Group, In 2018
- Figure 76: Medical and Healthcare Research & Development Spending, 2014-2017 (In USD Million)
- Figure 77: Research and Development Expenditure of total U.S. Pharmaceutical Industry, 2013-2017, (USD Billion)
- Figure 78: NIH Funding For Stem Cell Research, 2015-2018 (In USD Million)
- Figure 79: NIH Funding For Regenerative Medicine Research, 2015-2018 (In USD Million)
- Figure 80: Prevalence of cardiovascular diseases in United States, In million
- Figure 81: Prevalence of Wounds in United States, By Type, (Percentage of Total)
- Figure 82: Percentage of people with chronic health conditions in United States
- Figure 83: U.S. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 84: U.S. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 85: U.S. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 86: U.S. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 87: Canada Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 88: Canada Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 89: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
- Figure 90: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
- Figure 91: Healthcare Expenditure in Canada, By Source Breakdown, In USD million
- Figure 92: Canada Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 93: Canada Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 94: Canada Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 95: Canada Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 96: Europe Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
- Figure 97: Europe Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
- Figure 98: Regenerative Medicine in Clinical Trails, By Phase, 2018
- Figure 99: Europe Health Expenditure, By Select Country, 2017 & 2045 (% of GDP)
- Figure 100: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
- Figure 101: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
- Figure 102: European Union, Population ages 65 and above, 2013-2018 (% of total)
- Figure 103: Per Capita Health Expenditure, By Select Country, 2018 (USD)
- Figure 104: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
- Figure 105: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
- Figure 106: Europe Regenerative Medicine Market: Leading Companies (2018)
- Figure 107: Europe Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 108: Europe Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 109: Europe Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 110: Europe Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 111: Europe Regenerative Medicine Market Size, By Country, 2018 (%)
- Figure 112: Europe Regenerative Medicine Market Size, By Country, 2024F (%)
- Figure 113: Market Opportunity Chart of Europe Regenerative Medicine Market - By Type, By Value (Year - 2024)
- Figure 114: U.K. Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 115: U.K. Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 116: U.K, Total Number of Biotech Companies, By Sector, 2017
- Figure 117: U.K, Pharmaceutical R&D Spending, Euro Million, 2013-2016
- Figure 118: Proportional mortality in United Kingdom, In 2018
- Figure 119: Healthcare spending pattern in United Kingdom, In 2018
- Figure 120: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
- Figure 121: U.K, Population Ages 65 and Above (% of total), 2012-2018
- Figure 122: U.K. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 123: U.K. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 124: U.K. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 125: U.K. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 127: Germany Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 128: Germany Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 129: German Biotechnology companies expenditure on R&D, In Million Euros
- Figure 130: Prevalence of cardiovascular diseases in Germany, (In %)
- Figure 131: Proportional mortality in Germany, In 2018
- Figure 132: Healthcare spending pattern in Germany, In 2018, In USD
- Figure 133: Health insurance coverage in Germany, In 2018
- Figure 134: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
- Figure 135: Germany, Population ages 65 and above, 2012-2018 (% total)
- Figure 136: Germany Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 137: Germany Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 138: Germany Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 139: Germany Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 140: France Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 141: France Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 142: France, Number of Biotech Companies, By Type, 2017
- Figure 143: France, Prevalence of Cancer, 2018, (% of total)
- Figure 144: Prevalence of chronic diseases in France, In 2018
- Figure 145: Proportional mortality in France, In 2018
- Figure 146: Healthcare expenditure in France ( as a % of GDP)
- Figure 147: Healthcare spending pattern in France, In 2016 & 2050, In USD
- Figure 148: France Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 149: France Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 150: France Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 151: France Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 152: Italy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 153: Italy Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 154: Prevalence of chronic diseases in Italy, In 2018
- Figure 155: Prevalence of musculoskeletal condition in Italy, In million
- Figure 156: Prevalence of Chronic respiratory diseases in Italy, In Million
- Figure 157: Prevalence of cardiovascular diseases in Italy, In Thousands
- Figure 158: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
- Figure 159: Italy, Population Ages 65 and Above (% of total), 2012-2018
- Figure 160: Prevalence of skin diseases in Italy, In million
- Figure 161: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
- Figure 162: Italy Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 163: Italy Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 164: Italy Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 165: Italy Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 166: APAC Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
- Figure 167: APAC Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
- Figure 168: APAC, GDP, By Select Country, 2017 (In USD Trillion)
- Figure 169: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2018
- Figure 170: Obesity Rate, By Select Country, 2017 (In Percentage)
- Figure 171: Prevalence of musculoskeletal condition in Asia, 2013-2020F, In million
- Figure 172: Prevalence of chronic respiratory diseases in Asia, 2013-2020F, In million
- Figure 173: Population ages 65 and above, APAC Region, By Select Countries, 2018 (% of total)
- Figure 174: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
- Figure 175: APAC Regenerative Medicine Market: Leading Companies (2018)
- Figure 176: APAC Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 177: APAC Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 178: APAC Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 179: APAC Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 180: APAC Regenerative Medicine Market Size, By Country, 2018 (%)
- Figure 181: APAC Regenerative Medicine Market Size, By Country, 2024F (%)
- Figure 182: Market Opportunity Chart of APAC Regenerative Medicine Market - By Type, By Value (Year - 2024)
- Figure 183: India Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 184: India Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 185: India, Population ages 65 and above, 2013-2018, In Million
- Figure 186: India, Share of Urban Population, 2012-2018 (In %)
- Figure 187: Prevalence of musculoskeletal condition in India, 2013-2020E, In Million
- Figure 188: Prevalence of chronic respiratory diseases in India, In Million
- Figure 189: Prevalence of skin diseases in India, In Million
- Figure 190: Prevalence of cardiovascular disease in India, In million
- Figure 191: Growth of biotechnology industry in India
- Figure 192: Healthcare expenditure pattern in India, 2016 & 2050, In USD $
- Figure 193: Prevalence of non- communicable diseases in India, In 2018
- Figure 194: India, GDP Growth Per Year, 2015-2019F (In %)
- Figure 195: India, Total Population, 2013-2023F (In Million)
- Figure 196: India Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 197: India Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 198: India Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 199: India Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 200: Japan Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 201: Japan Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 202: Japan Healthcare Expenditure Outlook (2017) (%)
- Figure 203: Prevalence of diabetes in Japan, In million
- Figure 204: Prevalence of cardiovascular disease in Japan, In million
- Figure 205: Japan, Cancer Prevalence, By Type, (2018)
- Figure 206: Proportional mortality in Japan, In 2018
- Figure 207: Japan, GDP Growth Per Year, 2015-2019F (In %)
- Figure 208: Japan, Population ages 65 and above, 2012-2018 (% of total)
- Figure 209: Japan Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 210: Japan Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 211: Japan Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 212: Japan Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 213: China Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 214: China Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 215: Prevalence of cardiovascular disease in China, In million
- Figure 216: Prevalence of diabetes in China, In million
- Figure 217: China, Population ages 65 and above, 2012-2018 (% of total)
- Figure 218: China Healthcare Expenditure Outlook (2018) (%)
- Figure 219: China, GDP Growth Per Year, 2015-2019 (In %)
- Figure 220: China, Share of Urban Population, 2012-2018 (In %)
- Figure 221: China, Total Population, 2013-2021F (In Million)
- Figure 222: China Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 223: China Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 224: China Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 225: China Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 226: ROW Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
- Figure 227: ROW Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
- Figure 228: Cancer Prevalence in MENA (% of total), 2018
- Figure 229: Cancer Prevalence in Latin America & Caribbean , (% of total), 2018
- Figure 230: Population ages 65 and above, By Select Country, 2017 (% of total)
- Figure 231: Population ages 60 or above, By Select Country, 2050 (% of total)
- Figure 232: Prevalence of musculoskeletal condition in Middle East and North Africa, In USD million
- Figure 233: Prevalence of chronic respiratory disease in Middle East and North Africa, In USD million
- Figure 234: Latin America and Caribbean, Population ages 65 and above 2012-2018 (% of total)
- Figure 235: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2018
- Figure 236: Middle East and North Africa, Population ages 65 and above (% of total)
- Figure 237: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
- Figure 238: Prevalence of diabetes in Latin America ad Caribbean, In million
- Figure 239: Prevalence of diabetes in Middle East and North Africa, In million
- Figure 240: ROW Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 241: ROW Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 242: ROW Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 243: ROW Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 244: ROW Regenerative Medicine Market Size, By Country, 2018 (%)
- Figure 245: ROW Regenerative Medicine Market Size, By Country, 2024F (%)
- Figure 246: Brazil Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
- Figure 247: Brazil Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
- Figure 248: Prevalence of diabetes in Brazil, In million
- Figure 249: Prevalence of chronic respiratory diseases in Brazil, In million
- Figure 250: Brazil, Population ages 65 and above, 2012-18 (% of total)
- Figure 251: Brazil, GDP, 2012-2018 (In USD Trillion)
- Figure 252: Prevalence of cardiovascular disease in Brazil, In Million
- Figure 253: Brazil health expenditure as a share of GDP, 2018
- Figure 254: Brazil Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
- Figure 255: Brazil Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
- Figure 256: Brazil Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
- Figure 257: Brazil Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
- Figure 258: Global Regenerative Medicine Market Share, By Select Company, 2018 (In %)
- Figure 259: Global Regenerative Medicine Market - Pipeline Products, By Company
- Figure 260: Global Regenerative Medicine Market - Pipeline Products, By Therapeutic area
- Figure 261: Vericel, Sales Revenue, 2014-2018 (USD Million)
- Figure 262: Vericel, MACI and Carticel Sales Revenue, 2014-2018 (USD Million)
- Figure 263: Vericel, Epicel Sales Revenue, 2014-2018 (USD Million)
- Figure 264: Gilead Sciences, Sales Revenue, 2014-2018 (USD Billion)
- Figure 265: Novartis, Net Sales, 2014-2018 (In Billion USD)
- Figure 266: Novartis, Sales, By Innovative Medicine Segment, FY ended March 2018 (%)
- Figure 267: Novartis, Net Sales, By Geographic Region, 2018 (In %)
- Figure 268: Spark Therapeutics, Sales Revenue, 2016-2018 (USD Billion)
- Figure 269: Celgene Annual Sales Revenue, 2013-2017 (USD Billion)
- Figure 270: Celgene, Sales, By Regenerative Segment, FY ended March 2017 (%)
- Figure 271: Celgene, By Region, FY ended March 2017 (%)
- Figure 272: Sanofi Annual Sales Revenue of Cardiac and Vascular Group,2014-2018 (USD Million)
- Figure 273: Sanofi , Sales, By Business Segment, FY ended March 2018 (%)
- Figure 274: Sanofi, By Region, FY ended March 2018 (%)
- Figure 275: Amgen, Annual Sales Revenue, 2014-2018 (USD Billion)
- Figure 276: Amgen, By Region, FY ended March 2018 (%)
List of Tables
Table A: Top 10 countries with enormous stem cell research
Table B: Diseases curable by hematopoietic stem cell transplant in United States, In 2018
Table C: Funding received by California Institute of regenerative medicine
Table D: Accredited family cord blood banks in United States , In 2018
Table E: Facts about cardiovascular diseases in United States, In 2018
Table F: Accredited family cord blood banks in Canada , In 2018
Table G: Research funding of Stem Cell Network, Canada , In 2018, In CAD $
Table H: Research funding sources of Ontario Institute of Regenerative Medicine, In 2018, In CAD $
Table I: Prevalence of chronic conditions in Canada, In 2018, In percentage
Table J: Legislative and Governance framework for stem cell research in Europe
Table K: Disease burden and death from non-communicable diseases in European Region, In 2017
Table L: Regenerative Medicine Financing , 2018
Table M: Facts about chronic disease in Europe
Table N: EU-5 Socio-Economical Statistics, 2018
Table O: Causes of chronic diseases
Table P: Prevailing risk factors for chronic disease in United Kingdom, In 2018, In %
Table Q: Accredited family cord blood banks in Germany, In 2018
Table R: Top 5 countries with number of diabetic people across Europe, In million, In 2017
Table S: Germany, Healthcare Related Statistics, 2017
Table T: Accredited family cord blood banks in Italy, In 2018
Table U: Accredited family cord blood banks in India, In 2018
Table V: Accredited family cord blood banks in China, In 2018
Table W: Top 10 causes of death in China, In 2018
Table X: Prevailing risk factors for chronic diseases across China, In 2018
Table Y: Accredited family cord blood banks in Brazil, In 2018
Table Z: Prevailing risk factors for Chronic diseases across Brazil, In 2018
Table AA: Healthcare spending pattern in Brazil (In USD)
Table AB: Recent Company Collaborations, Partnerships and Alliances in Regenerative medicine Market
Table AC: FDA approved cellular and gene therapy products
Table AD: Cell and Gene Therapy approved by European Medicines Agency
